Malignant Pleural Effusions (Mpe)
10
5
5
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (10)
Safety and Feasibility of Medical Thoracoscopy Using Single-use Flexible Bronchoscope Versus SemiRigid Pleuroscope in Pleural Effusion
Xuan Yin Ning Plus Bevacizumab for Malignant Pleural Effusion
Ex Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma
A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion
First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion
Impact of Pleural Manometry on the Assessment and Treatment of Malignant Pleural Effusion: A Pilot Clinical Trial
ARMSTRONG - Air entRainMent vS sTandard tReatment in nOn-expandable luNG
A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
The Outcome of Inserting Intercostal Tube or Pleurodesis for Malignant Pleural Effusion
Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin